How many insider declarations has Cobb Stuart filed?

Cobb Stuart has filed 4 public insider declarations with SEC (Form 4).

What is Cobb Stuart's role?

Cobb Stuart's reported role is not specified by the regulator across the filings.

Which companies does Cobb Stuart report trades for?

Cobb Stuart reports trades for Neurogene Inc..

What is Cobb Stuart's declared buy vs sell volume?

Across the available history, declared buys total 0 and disposals 163k€.

← Executives ★ Sign in to follow

CS

Cobb Stuart

OFFICER

·SEC (Form 4)

Neurogene Inc.

0

申报总数

0

公司

—

▲ 买入（0 笔）

€162,814

▼ 卖出（2 笔）

内部人交易记录

其他

已披露买入

0

已披露卖出

2

T+90 胜率

100%

T+90 平均收益

+45.1%

基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。

信号历史

Explore the detailed record of transactions filed by Cobb Stuart. Officer active across 1 company, notably Neurogene Inc.. Aggregated, 4 disclosures have been recorded. Breakdown: 0 buy · 2 sells. Total volume traded: €163k. History available since 13 March 2024. The latest transaction was disclosed on 13 March 2026 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.

Companies and markets linked to Cobb Stuart

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Neurogene Inc. (US)

申报4 总计

▼

Cobb Stuart

Chief Scientific Officer高管2026年3月13日Neurogene Inc.

US$81,4560SEC ↗

3,991 股@ US$20.41Common StockSEC:0001994301-26-000004:0

▼

Cobb Stuart

Chief Scientific Officer高管2025年5月14日Neurogene Inc.

US$103,00319SEC ↗

6,797 股@ US$15.1542100.0% 占其流量Common StockSEC:0001404644-25-000046:0

◆

Cobb Stuart

Chief Scientific Officer高管2025年3月26日Neurogene Inc.

11SEC ↗

7,200 股0Common StockSEC:0001404644-25-000025:0

◆

Cobb Stuart

Chief Scientific Officer高管2024年3月13日Neurogene Inc.

11SEC ↗

20,391 股0Common StockSEC:0001404644-24-000006:0

4 条申报中的 4 条

InsidersTradesSigma

← Executives ★ Sign in to follow

CS

Cobb Stuart

OFFICER

·SEC (Form 4)

Neurogene Inc.

0

申报总数

0

公司

—

▲ 买入（0 笔）

€162,814

▼ 卖出（2 笔）

内部人交易记录

其他

已披露买入

0

已披露卖出

2

T+90 胜率

100%

T+90 平均收益

+45.1%

基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。

信号历史

Explore the detailed record of transactions filed by Cobb Stuart. Officer active across 1 company, notably Neurogene Inc.. Aggregated, 4 disclosures have been recorded. Breakdown: 0 buy · 2 sells. Total volume traded: €163k. History available since 13 March 2024. The latest transaction was disclosed on 13 March 2026 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.